MicroRNA and epilepsy: profiling, functions and potential clinical applications

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Epilepsy is a complex neurological disorder characterized by recurrent seizures.
• MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression post-transcriptionally.
• Understanding miRNA dysregulation in epilepsy is crucial for developing novel therapeutic and diagnostic strategies.

Purpose of the Study:

• To synthesize recent profiling studies on miRNA alterations in experimental and human epilepsy.
• To explore the mechanistic, therapeutic, and diagnostic potential of miRNAs in epilepsy.
• To provide an overview of the current research landscape for clinical application.

Main Methods:

• Large-scale expression profiling of miRNAs in experimental and human epilepsy models.
• Analysis of miRNA biogenesis and function-related enzyme levels in epileptic brain tissue.
• Functional studies using oligonucleotide-based miRNA inhibitors.

Main Results:

• Over 100 different miRNAs showed altered expression in the hippocampus in epilepsy.
• Specific miRNAs, including miR-23a, miR-34a, miR-132, and miR-146a, were consistently dysregulated.
• Altered levels of Dicer and Argonaute 2, key miRNA biogenesis enzymes, were observed.
• Functional studies implicated miRNAs in regulating cell death, synaptic structure, inflammation, and immune response.
• Epilepsy-associated brain injuries generated unique miRNA profiles in biofluids.

Conclusions:

• MicroRNAs play a significant role in controlling protein levels and cellular processes in epilepsy.
• miRNAs hold promise as therapeutic targets for preventing or treating epilepsy.
• miRNAs may serve as valuable diagnostic biomarkers for identifying and monitoring epileptogenesis.